An analyst from TD Cowen maintained Walgreens Boots (NASDAQ: WBA) at 'outperform' with a price target of $37.00 from a prior price target of %currency%%price%. Prior to this rating,...
Insurers, including Blue Cross and Blue Shield of Minnesota, are urging a U.S. judge to reject what they consider a "grossly inflated" request for legal fees from national retail pharmacy...
An analyst from Deutsche Bank maintained Walgreens Boots (NASDAQ: WBA) at 'hold' with a price target of $27.00 from a prior price target of %currency%%price%. Prior to this rating,...
Walgreens Boots Alliance (NASDAQ: NASDAQ:WBA) and CVS Health (NYSE: NYSE:CVS), two leading pharmacy retailers, offer attractive yields to investors. However, the companies' differing...
Walgreens (NYSE:WBA) shares are trading at $22 each as of Thursday, marking a significant decrease of nearly 60% since March 2021. This downturn contrasts with the S&P 500's 18% gain during...
The Dow Jones Industrial Average, a barometer of Wall Street's health for over 127 years, is considering a reshuffle that may see three of its constituents - Walgreens Boots Alliance...
CHICAGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Beginning September 16th, Walgreens, a pharmacy and retail leader who plays a critical role in the U.S. healthcare system by providing a wide...
The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products violating federal law. The companies include CVS Health Corp (NYSE:...
Two of the country's largest drug store chains have received warning letters from the FDA for selling unapproved eye drops.
Walgreens, Goldman Sachs top blue-chip gainers as Dow turns upward at midday
The U.S. Food and Drug Administration this week warned CVS Health Corp. CVS, Walgreens Boots Alliance Inc. WBA and several smaller consumer products companies about marketing unapproved eye...
Walgreens, a division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), and Pearl Health, a leading provider enablement company, today announced a partnership to accelerate the expansion of...
Ariel Investments, an investment management firm, highlighted Walgreens Boots Alliance, Inc. (NASDAQ:WBA) and Northern Trust Corporation (NASDAQ:NASDAQ:NTRS) in its second-quarter 2023...
Dow, Nike, Merck and Walgreens are sharpest blue-chip decliners on Tuesday
Rosalind Brewer, the chief executive officer of Walgreens Boots Alliance (NASDAQ:WBA), has stepped down from her role on Monday. Brewer's departure from the company is described as a...
Airbnb and Blackstone to join S&P 500; Deere replacing Walgreens in S&P 100
Blackstone Inc. BX and Airbnb Inc. ABNB will join the S&P 500 index SPX before trading opens on Sept. 18, replacing Lincoln National Corp. LNC and Newell Brands Inc. NWL, S&P Dow Jones...
Graham, a longtime board member, is running the company alongside an interim CFO.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has announced a leadership change today. Rosalind Brewer, the company's CEO, will be stepping down from her role as CEO and as a member of the...
Investing.com -- U.S. futures traded higher Friday, as investors awaited the release of the official monthly jobs report for clues of future Federal Reserve monetary policy decisions. Here...
Walgreens Boots Alliance (WBA) expects full-year 2023 adjusted EPS to be at or near the low end of its previously stated range. The Company will discuss 2024 guidance at its next regularly...
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that the Board of Directors and Rosalind Brewer have mutually agreed that Ms. Brewer will step down as the Company’s Chief...
Shares of Walgreens Boots Alliance Inc. WBA rose 0.4% in premarket trading Thursday, but were still headed for their worst monthly performance in more than four years. The drugstore chain...
An analyst from Evercore ISI maintained Walgreens Boots (NASDAQ: WBA) at 'in line' with a price target of $26.00 from a prior price target of %currency%%price%. Prior to this rating,...
An analyst from Credit Suisse maintained Walgreens Boots (NASDAQ: WBA) at 'neutral' with a price target of $30.00 from a prior price target of %currency%%price%. Prior to this rating,...
The 4th U.S. Circuit Court of Appeals in Richmond, Virginia, reinstated a lawsuit where the U.S. and Virginia allege Walgreens Boots Alliance Inc (NASDAQ: WBA) fraudulently claimed some...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
